Adenosine

腺苷

Report date: 2022/12/07 17:07:17
NME

Base Information

Drug NameAdenosine
Drug Alias Name腺甘酸腺嘌呤核苷腺甙Adenocard艾吉伴 +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionAdenosine A1 receptor agonists
TargetsAdenosine A1 receptor
Therapy Area/IndicationsIschemiaVascular DiseasesMyocardial Infarction +[11] 
Global Approved IndicationsTachycardia, SupraventricularTachycardia
Approved Indications in ChinaTachycardia
Original Approved Country/TerritoryUnited States
Original Approved Date1989/10/30
Country/TerritoryCanadaUnited StatesSouth Africa +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesWinthrop Us
Inactive CompaniesInstituto De Ciencias Del CorazonLudwig Maximilians University Of MunichUniversity Of Calgary +[11] 
Active IndicationsTachycardia
Inactive IndicationsIschemiaVascular DiseasesMyocardial Infarction +[10] 

Other Information

ATC CodeC01EB10
Related LinksWikipediaDrugBankKEGG